*4.2.2.4 Non-traceability of samples because of wrong allocation of samples during storage*


### *Risk Management in Biobanks DOI: http://dx.doi.org/10.5772/intechopen.91463*

• Lack of time

**Possible consequences**

*Risk Management and Assessment*

**Possible coping strategy**

• Regular process monitoring

**Possible reasons**

• Incorrect packaging

• Loss of image

*storage*

**Possible reasons**

• Bad documentation

• No well-trained staff

**90**

**Possible consequences**

• Samples are no longer usable

• No fulfillment of the contract

**Possible coping strategy**

• Additional costs for the biobank

• Image loss

• Output of samples with wrong clinical data ! cause error results

• Continuous improvement of data administration

• Wrong or inadequate labeling for shipment

*4.2.2.3 Incorrect handling of samples in the frame of sample shipment*

• Testing of all available shipment companies with exact documentation, for decision about a partner in shipment (including cost–service calculation)

• Exact procedure description of labeling and packaging with easy availability

*4.2.2.4 Non-traceability of samples because of wrong allocation of samples during*

• Continuous training of personnel involved in shipment

• Loss of attention while manual labeling samples

• Badly readable sample codes by poorly labeling

for the personnel (with exact pictures and measurements)

• High error rate of systems for storage of samples or for input of sample-related data
